Champions Oncology Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Monitoring Framework
Key Performance Indicators
Core Study Service Revenue Quarterly16.6M
Oncology Services Gross Margin Quarterly4,700.0%
Adjusted EBITDA Quarterly574K
Watch Items
- In-sourcing of outsourced laboratory services (specifically radiolabeling)Trigger: Gross margin improvement toward historical >50% levelsAction: Monitor quarterly cost of oncology services and gross margin trends.
- Securing external venture capital or licensing partners for Corellia AI subsidiaryTrigger: Execution of external funding or partnership agreementAction: Review quarterly corporate updates and cash flow statements for subsidiary funding.
- Data licensing transaction pipelineTrigger: Closing of new high-margin data dealsAction: Track non-study service revenue and management commentary on data business momentum.
Research as of 19 Jun 2026